Maria Natalia Gandur Quiroga: Whole-body MRI for staging in high-risk prostate cancer

Maria Natalia Gandur Quiroga shared a post on X, about recent paper published in Prostate Cancer and Prostatic Diseases:

Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer.

Authors: Andrew M. Fang, Brian F. Chapin, Charles W. Shi, Jia Sun, Aliya Qayyum, Vikas Kundra, Paul G. Corn, Deborah A. Kuban, Gregory C. Ravizzini, Devaki Shilpa S. Surasi, Jingfei Ma and Tharakeswara K. Bathala.

”Whole-body MRI for staging in high-risk prostate cancer.

The study compared WBMRI (whole-body magnetic resonance imaging) with conventional imaging (CT and BS).

WBMRI showed higher sensitivity in detecting lymphatic metastases (60% vs. 20%, p = 0.031).

For bone metastases, WBMRI performed similarly to computed tomography plus bone scintigraph (sensitivity 25%).

WBMRI is proposed as a ‘one-stop-shop’ option for better staging in high-risk prostate cancer (HRPCa).

Implications: Improved surgical and radiotherapy planning where prostate-specific membrane antigen positron emission tomography (PSMA PET) is not available.”

Source: Maria Natalia Gandur Quiroga/X

Maria Natalia Gandur Quiroga is a Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at the Ángel H. Roffo Oncology Institute in Buenos Aires, Argentina. She is a Professor of Medicine at the University of Buenos Aires at the Oncologists Post Graduates Studies. Her research focuses on clinical trials with aims to improve the treatment of patients with urologic tumors.  She is an active member of the European Association for Cancer Research, Argentinian Medical Association and American Society of Clinical Oncology.